Since July 9, the Ticovac 0.25 ml children’s vaccine from the Pfizer laboratory is out of stock. Recommended for certain trips, the vaccine prevents tick-borne encephalitis. The national security and drug agency (ansm) announces this stock shortage on its site. This should last until the end of July at the earliest, according to the agency. A “limited availability [est] scheduled from the week of July 30 “, further specifies ANSM.
Tick-borne encephalitis are viral diseases caused by a virus (arbovirus) transmitted to humans through the tick bite infected. After an incubation of one to two weeks, the disease develops suddenly with first symptoms like flu, accompanied by fever, headache and chills.
The tick-borne encephalitis vaccine is recommended for adults and children over 1 year of age when full stays are planned in areas where the disease is present (central, eastern and northern Europe, northern Europe). ‘Central Asia, northern China, northern Japan). Travelers who must reside in rural or wooded areas of the affected regions, from spring to autumn, are encouraged to be vaccinated to reduce the risk of contracting the disease, reports the vaccination-info-service site.
Few cases of tick-borne encephalitis in France
From 5,000 to 13,000 cases of tick-borne encephalitis are reported each year worldwide. Tick-borne encephalitis remains very rare in France. It is currently rife in Eastern Europe, northern Japan and China.
In addition to vaccines, wearing closed shoes and covering clothing possibly impregnated with repellents is among the good reflexes to have for protect yourself from ticks. A smartphone application, Tick alert, to indicate the presence of ticks to walkers is also available.
[#EtéSansSouci☀] Our advice to avoid the stings and bites of summer and the right reflexes to react to them https://t.co/hXESBxu9Fd
– ANSM (@ansm) July 16, 2018
Read also
Why mosquitoes bite en masse this summer
In Toulouse the war against the tiger mosquito is declared
